ThreatNG Security Offers Free Access to Their Groundbreaking Security Platform for Organizations to Assess Cloud and SaaS Vulnerabilities
28.2.2023 17:00:00 EET | Business Wire | Press release
ThreatNG, a cybersecurity company dedicated to empowering organizations of all sizes to manage their external attack surface and digital risks, has announced the release of its agentless Cloud and SaaS Exposure Assessment Module. The company also announced free access to organizations to this groundbreaking platform to assess their external risk for a limited time.
The ThreatNG “Cloud and SaaS Exposure” Module supports the following vendors and technology categories:
- Amazon Web Services (AWS)
- Microsoft Azure
- Google Cloud Platform (GCP)
- Analytics
- Business Intelligence (BI)
- Customer Relationship Management (CRM)
- File Sharing
- Human Resources
- Security
- Video Telephony
ThreatNG continues to redefine External Attack Surface Management (EASM), Digital Risk Protection, and Security Ratings by announcing the availability of its Agentless Cloud and SaaS Exposure Assessment Module. Requiring only a domain and organization name, ThreatNG users can perform Outside-In Discovery, Assessment, Reporting, and Monitoring of their Cloud and SaaS Footprint, uncover Exposed Open Cloud Buckets, bring to light Unsanctioned Implementations (Shadow IT), and call to attention Brand Impersonations (Cybersquats) without using agents, credentials, API connections, browser plugins, and any other means that require prior knowledge.
ThreatNG further empowers its users by providing a differentiated, unmatched, and holistic approach by extending discovery and assessment of all Internet-exposed online applications, repositories, APIs, platform-as-a-service (PaaS), infrastructure-as-a-service (IaaS), and vendor technologies interconnected with Cloud and SaaS implementations.
“As more critical data and functions are migrating to the cloud, it becomes much more important for organizations to have visibility of all their digital assets exposed to the public and address all potential risks and threats. Our Cloud and SaaS Exposure module empower users with a proactive outside-in perspective,” said Eric Gonzales, founder of ThreatNG. “We are so confident in our technology’s capability that we are willing to provide organizations of all sizes with a free discovery and risk assessment of their Cloud and SaaS environments.”
To learn more about ThreatNG and its Cloud and SaaS Exposure Assessment capabilities, visit the company’s website, www.threatngsecurity.com/cloudexposure.
Cloud and SaaS Environments are continuously evolving. With new instances appearing, this constant change makes it challenging to keep an accurate inventory of sanctioned implementations and maintain good cyber hygiene overall. This growing Cloud and SaaS sprawl feeds into the ever-increasing problem of Shadow IT (Unsanctioned Implementations) and Cybersquats (Brand Impersonations). This uncontrollable sprawl has also led to increased security risks and exposures, a growth in phishing attacks abusing SaaS platforms, and cloud assets compromised more than on-premise assets (Verizon 2022 Data Breach Investigations Report).
Cloud and SaaS Impersonations (Cybersquats) and Exposed Data within Open Cloud Buckets are growing problems with organizations of all sizes and their Third Parties. Still, they are out of scope within most External Attack Surface Management (EASM), Digital Risk Protection, and Security Rating Services. ThreatNG unites these solution capabilities and empowers users to seamlessly bring Cloud and SaaS into the fold of Asset Inventory, Security & Governance, Subsidiary Security Monitoring, Third-Party Security Assessments, and Brand Protection through their innovative external discovery and assessment requiring only a domain and organization name.
Support for all of the above is available today and accompanied by all of the following investigation modules provided to all ThreatNG users:
- Domain Intelligence
- Technology Stack
- Sensitive Code Exposure
- Online Sharing Exposure
- Search Engine Exploitation
- Sentiment and Financials
- Archived Web Pages
- Social Media
- Dark Web
Contact ThreatNG Security today for a Free 30-Day Evaluation of their Cloud and SaaS Exposure Assessment Module.
About ThreatNG
ThreatNG is redefining external attack surface management (EASM), digital risk protection, and security ratings with a platform of unmatched breadth, depth, and capabilities in managing technical and business threats across the dark, deep, and open web. Living up to the company mantra (“Security Centric; Not Exclusive”), ThreatNG provides a configurable solution to target, discover, and assess digital assets across a definable ecosystem of organizations, subsidiaries, partners, third parties, supply chains, and customers. Bolstered and maintained by the open source intelligence (OSINT) experts at DarcSight Labs, ThreatNG empowers organizations of all types and sizes to uncover, understand, and manage their external digital threats.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230227005863/en/
Contact information
Erin Price
Email: erin@threatngsecurity.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 23:30:00 EET | Press release
Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to
Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 23:30:00 EET | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that
Multi-Color Corporation Receives Court Approval of First Day Motions4.2.2026 22:30:00 EET | Press release
Multi-Color Corporation (“MCC” or the “Company”), a global leader in prime label solutions, today announced that it has received approval from the U.S. Bankruptcy Court for the District of New Jersey (the “Court”) for first day relief related to its prepackaged Chapter 11 filed on January 29, 2026. The approved relief affirms that the Company will operate in the normal course, pay all trade vendors and suppliers in full, and maintain a strong liquidity position during the restructuring. As part of this relief, the Court granted MCC immediate access to $125 million of $250 million in debtor-in-possession (“DIP”) new money financing, provided by certain holders of MCC’s secured first lien debt and its equity sponsor, CD&R. This funding will capitalize the business through the initial stages of the prepackaged Chapter 11 process. The Court also granted MCC authority to pay trade vendors and suppliers in full in the ordinary course, maintain wages and benefits without interruption, satisfy
InterSystems Honored with Four 2026 Best in KLAS Awards4.2.2026 19:00:00 EET | Press release
InterSystems, a creative data technology provider powering more than one billion health records globally, today announced it has received four Global 2026 Best in KLAS awards. The company earned a #1 ranking for Acute Care EHR in Asia, Oceania, and France, as well as for Shared Care Records in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260204241673/en/ InterSystems earns four Best in KLAS awards for 2026 Best in KLAS is KLAS Research’s annual recognition of top-performing healthcare technology and services solutions, based entirely on feedback from healthcare provider organizations. Awards are given within defined software and services market segments evaluated by KLAS Research using a standardized methodology that reflects customer experience and performance. In addition to U.S. market segments, KLAS also recognizes top-performing solutions through its Global (Non-U.S.) Best in KLAS Awards, which are based on fe
Onego Bio Strengthens Board with Appointment of Dr. Antti Vasara4.2.2026 17:00:00 EET | Press release
Onego Bio, the food ingredient company producing non-animal egg protein through precision fermentation, today announced that Dr. Antti Vasara has joined its board of directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260204881159/en/ Dr. Antti Vasara Dr. Vasara brings more than 25 years of global experience in science, technology, and commercial strategy. Most recently, he served as President and CEO of VTT Technical Research Centre of Finland, where he led one of Europe’s foremost deep tech research organizations. His distinguished career spans senior leadership roles in industry and innovation policy—including impactful work with Nokia and strategic contributions to European research and development initiatives. “Antti is one of the most respected leaders in science and innovation,” said Maija Itkonen, CEO of Onego Bio. “His deep understanding of technology commercialization and ecosystem level strategy will be inva
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
